Semaglutide, the active ingredient in Novo Nordisk's Ozempic and Wegovy, has been linked to an eye condition that can cause blindness, a new study has found. In the journal JAMA Ophthalmology, Harvard scientists report that people who'd been prescribed semaglutide, a glucagon-like peptide-1 (GLP-1) agonist that mimics the stomach's feeling of fullness, were between four and […]